| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |